Medlive Technology Co., Ltd. (HKG: 2192)
Hong Kong
· Delayed Price · Currency is HKD
8.73
+0.01 (0.11%)
Jan 28, 2025, 12:08 PM HKT
Medlive Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Revenue | 481.94 | 412 | 314.05 | 284.44 | 213.53 | 121.57 | Upgrade
|
Revenue Growth (YoY) | 35.53% | 31.19% | 10.41% | 33.21% | 75.64% | 45.66% | Upgrade
|
Cost of Revenue | 188.5 | 160.67 | 101.31 | 83.71 | 57.29 | 46.49 | Upgrade
|
Gross Profit | 293.44 | 251.34 | 212.74 | 200.73 | 156.24 | 75.08 | Upgrade
|
Selling, General & Admin | 196.39 | 177.13 | 151.34 | 127.67 | 52.68 | 37.21 | Upgrade
|
Other Operating Expenses | -2.2 | 9.07 | 1.58 | 11.46 | 0.05 | 0.67 | Upgrade
|
Operating Expenses | 194.19 | 186.2 | 152.92 | 139.13 | 52.72 | 37.88 | Upgrade
|
Operating Income | 99.26 | 65.14 | 59.82 | 61.6 | 103.51 | 37.2 | Upgrade
|
Interest Expense | -0.43 | -0.36 | -0.53 | -0.54 | -0.21 | -0.3 | Upgrade
|
Interest & Investment Income | 205.46 | 184.67 | 66.96 | 7.84 | 1.09 | 0.08 | Upgrade
|
Earnings From Equity Investments | 0 | 0.01 | 0.01 | -0 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.43 | - | - | - | - | 0.01 | Upgrade
|
Other Non Operating Income (Expenses) | 4.03 | 3.81 | 8.78 | 1.02 | 0 | 0.01 | Upgrade
|
EBT Excluding Unusual Items | 308.75 | 253.26 | 135.04 | 69.93 | 104.4 | 37 | Upgrade
|
Merger & Restructuring Charges | -0.13 | -0.13 | - | - | - | - | Upgrade
|
Other Unusual Items | - | - | - | - | 0.45 | - | Upgrade
|
Pretax Income | 308.62 | 253.13 | 135.04 | 69.93 | 104.85 | 37 | Upgrade
|
Income Tax Expense | 5.81 | 1.37 | 8.62 | 24.68 | 19.65 | 5.73 | Upgrade
|
Earnings From Continuing Operations | 302.81 | 251.76 | 126.42 | 45.25 | 85.2 | 31.27 | Upgrade
|
Minority Interest in Earnings | -12.51 | -9.46 | -9.1 | -4.63 | - | - | Upgrade
|
Net Income | 290.3 | 242.3 | 117.32 | 40.62 | 85.2 | 31.27 | Upgrade
|
Net Income to Common | 290.3 | 242.3 | 117.32 | 40.62 | 85.2 | 31.27 | Upgrade
|
Net Income Growth | 53.55% | 106.53% | 188.85% | -52.33% | 172.46% | 120.38% | Upgrade
|
Shares Outstanding (Basic) | 726 | 722 | 714 | 616 | 535 | 535 | Upgrade
|
Shares Outstanding (Diluted) | 736 | 735 | 737 | 636 | 535 | 535 | Upgrade
|
Shares Change (YoY) | 0.03% | -0.26% | 15.84% | 18.82% | -0.07% | 0.00% | Upgrade
|
EPS (Basic) | 0.40 | 0.34 | 0.16 | 0.07 | 0.16 | 0.06 | Upgrade
|
EPS (Diluted) | 0.39 | 0.33 | 0.16 | 0.06 | 0.16 | 0.06 | Upgrade
|
EPS Growth | 53.55% | 107.09% | 149.30% | -59.86% | 172.60% | 120.38% | Upgrade
|
Free Cash Flow | 90.31 | 101.12 | 75.84 | 42.47 | 110.42 | 25.78 | Upgrade
|
Free Cash Flow Per Share | 0.12 | 0.14 | 0.10 | 0.07 | 0.21 | 0.05 | Upgrade
|
Dividend Per Share | 0.245 | 0.232 | 0.065 | 0.017 | - | - | Upgrade
|
Dividend Growth | 42.53% | 253.98% | 284.71% | - | - | - | Upgrade
|
Gross Margin | 60.89% | 61.00% | 67.74% | 70.57% | 73.17% | 61.76% | Upgrade
|
Operating Margin | 20.60% | 15.81% | 19.05% | 21.66% | 48.48% | 30.60% | Upgrade
|
Profit Margin | 60.24% | 58.81% | 37.36% | 14.28% | 39.90% | 25.72% | Upgrade
|
Free Cash Flow Margin | 18.74% | 24.54% | 24.15% | 14.93% | 51.71% | 21.20% | Upgrade
|
EBITDA | 103.93 | 69.05 | 61.72 | 63.73 | 106.17 | 39.14 | Upgrade
|
EBITDA Margin | 21.56% | 16.76% | 19.65% | 22.41% | 49.72% | 32.20% | Upgrade
|
D&A For EBITDA | 4.67 | 3.91 | 1.9 | 2.13 | 2.66 | 1.94 | Upgrade
|
EBIT | 99.26 | 65.14 | 59.82 | 61.6 | 103.51 | 37.2 | Upgrade
|
EBIT Margin | 20.59% | 15.81% | 19.05% | 21.66% | 48.48% | 30.60% | Upgrade
|
Effective Tax Rate | 1.88% | 0.54% | 6.38% | 35.30% | 18.74% | 15.48% | Upgrade
|
Advertising Expenses | - | - | - | - | - | 3.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.